NO20040981L - Fremgangsmate for fremstilling av 4-(imidazol-1-yl)benzensulfonamidderivater. - Google Patents

Fremgangsmate for fremstilling av 4-(imidazol-1-yl)benzensulfonamidderivater.

Info

Publication number
NO20040981L
NO20040981L NO20040981A NO20040981A NO20040981L NO 20040981 L NO20040981 L NO 20040981L NO 20040981 A NO20040981 A NO 20040981A NO 20040981 A NO20040981 A NO 20040981A NO 20040981 L NO20040981 L NO 20040981L
Authority
NO
Norway
Prior art keywords
imidazol
preparation
formula
benzenesulfonamide derivatives
benzenesulfonamide
Prior art date
Application number
NO20040981A
Other languages
English (en)
Other versions
NO326162B1 (no
Inventor
Carmen Almansa Rosales
Concepcion Gonzalez Gonzalez
Original Assignee
Uriach Y Compania Sa J
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uriach Y Compania Sa J filed Critical Uriach Y Compania Sa J
Publication of NO20040981L publication Critical patent/NO20040981L/no
Publication of NO326162B1 publication Critical patent/NO326162B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
    • C07C311/39—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/40—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68—Halogen atoms

Abstract

Fremgangsmåte for fremstilling av 4- (imidazol-1-yl)benzensulfonamidderivater med formel I. hvor Rrepresenterer eventuelt substituert aryl eller heteroaryl, som omfatter å behandle en forbindelse med formel II. hvor Rhar samme betydning som definert i formel I, og Bu' representerer tert.-butyl, med en syre. 4-(imidazol- l-yl)-benzensulfonamidderivatene med formel I er anvendelige som antiinflammatoriske midler.
NO20040981A 2001-08-07 2004-03-05 Fremgangsmate for fremstilling av 4-(imidazol-1-yl)benzensulfonamidderivater. NO326162B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200101853A ES2184633B1 (es) 2001-08-07 2001-08-07 Procedimiento para la preparacion de derivados de 4-(imidazol-1-il) bencenosulfonamida.
PCT/ES2002/000385 WO2003016285A1 (es) 2001-08-07 2002-08-01 Procedimiento para la preparacion de derivados de 4-(imidazol-1-il)bencenosulfonamida

Publications (2)

Publication Number Publication Date
NO20040981L true NO20040981L (no) 2004-03-05
NO326162B1 NO326162B1 (no) 2008-10-13

Family

ID=8498662

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040981A NO326162B1 (no) 2001-08-07 2004-03-05 Fremgangsmate for fremstilling av 4-(imidazol-1-yl)benzensulfonamidderivater.

Country Status (17)

Country Link
US (2) US7351836B2 (no)
EP (1) EP1424329B1 (no)
JP (1) JP4309262B2 (no)
KR (1) KR100888905B1 (no)
AR (2) AR037231A1 (no)
AT (1) ATE396976T1 (no)
BR (1) BRPI0211749B8 (no)
CA (1) CA2456531C (no)
CY (1) CY1108861T1 (no)
DE (1) DE60226879D1 (no)
DK (1) DK1424329T3 (no)
ES (2) ES2184633B1 (no)
HK (1) HK1066214A1 (no)
MX (1) MXPA04001147A (no)
NO (1) NO326162B1 (no)
PT (1) PT1424329E (no)
WO (1) WO2003016285A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2015DN00202A (no) 2012-07-12 2015-06-12 Chiesi Farma Spa
WO2022269384A1 (en) * 2021-06-24 2022-12-29 Ami Organics Ltd. A process for the direct synthesis of fedratinib intermediate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TNSN99111A1 (fr) * 1998-06-11 2005-11-10 Pfizer Derives de sulfonylbenzene nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
DE69935913T2 (de) * 1998-07-02 2008-01-10 Cryptography Research Inc., San Francisco Leckresistente aktualisierung eines indexierten kryptographischen schlüssels
AR024222A1 (es) * 1998-10-16 2002-09-25 Palau Pharma Sa Imidazoles con actividad antiinflamatoria un procedimiento para su preparacion y composiciones farmaceuticas que lo contienen
ES2159489B1 (es) 2000-03-23 2002-04-16 Uriach & Cia Sa J Nuevos derivados de imidazol con actividad antiinflamatoria.

Also Published As

Publication number Publication date
AR086065A2 (es) 2013-11-13
KR20040020079A (ko) 2004-03-06
ES2184633A1 (es) 2003-04-01
US8476456B2 (en) 2013-07-02
MXPA04001147A (es) 2004-07-08
AR037231A1 (es) 2004-11-03
ES2307817T3 (es) 2008-12-01
JP2005502659A (ja) 2005-01-27
CY1108861T1 (el) 2014-08-13
NO326162B1 (no) 2008-10-13
KR100888905B1 (ko) 2009-03-16
CA2456531A1 (en) 2003-02-27
BR0211749B1 (pt) 2013-09-10
DE60226879D1 (de) 2008-07-10
WO2003016285A8 (es) 2003-08-28
ATE396976T1 (de) 2008-06-15
EP1424329A1 (en) 2004-06-02
WO2003016285A1 (es) 2003-02-27
EP1424329B1 (en) 2008-05-28
US7351836B2 (en) 2008-04-01
BR0211749A (pt) 2004-10-13
US20090012307A1 (en) 2009-01-08
HK1066214A1 (en) 2005-03-18
ES2184633B1 (es) 2004-08-01
BRPI0211749B8 (pt) 2021-05-25
DK1424329T3 (da) 2008-09-29
CA2456531C (en) 2010-12-14
JP4309262B2 (ja) 2009-08-05
PT1424329E (pt) 2008-08-06
US20040242872A1 (en) 2004-12-02

Similar Documents

Publication Publication Date Title
NO20034011L (no) Steroider som agonister for FXR
NO941677L (no) Tetrazolderivater av gallesyrer, fremgangsmåter for fremstilling og deres anvendelse som legemiddel
NO20062292L (no) Fremgangsmate for behandling av transplantasjonsavstoting
ATE296826T1 (de) Pyrazolo(1,5)pyridinderivate
DK0977741T3 (da) Substituerede phenylderivater, deres fremstilling og anvendelse
EE200200091A (et) N-heterotsüklilised derivaadid kui NOSi inhibiitorid
TR200201072T2 (tr) 4-Triflorometilsulfinilpirazol türevi hazırlama süreci
AU2002239344A1 (en) Pyrazolopyridines
WO2004002986A3 (en) Novel benzimidazole derivatives
NO20025821L (no) 2-aminokarbonyl-9H-purinderivater
DK5389D0 (da) Substituerede pyrroler, pyrazoler og triazoler, fremgangsmaader til deres fremstilling samt deres anvendelse som angiotensin ii-antagonister
BR0112965A (pt) Derivados de 3-indolil-4-fenil-1h-pirrol-2,5-diona como inibidores de glocogênio sintase cinase-3beta
NO20030301L (no) Nye heteroarylderivater og anvendelse derav som farmasöytika
AU2002246728A1 (en) Carboline derivatives
NO20022202D0 (no) 5-aryl-1H-1,2,4-triazol forbindelser som inhibitorer av cyclooksygenase-2 og farmasöytiske preparater inneholdende disse
AU2002239348A1 (en) Pyrazolopyridine derivatives
TR200201168T2 (tr) CGRP-Antagonistleri-yeni siklopropanlar içeren ilaçlar ve üretim yöntemleri.
TR28332A (tr) Arilasetik asit türevleri.
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
RU95106653A (ru) Производные 2-имидазолин-5-онов и 2-имидазолин-5-тионов и фунгицидные композиции на их основе
NO20040981L (no) Fremgangsmate for fremstilling av 4-(imidazol-1-yl)benzensulfonamidderivater.
AU2002248531A1 (en) Pyrazolopyriadine derivatives
AU2002357740A1 (en) Pyrazolo-pyridine derivatives as antiherpes agents
WO2002074735A3 (de) Biurethanderivate
SE0003795D0 (sv) Pharmaceutically useful compounds

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees